PuSH - Publication Server of Helmholtz Zentrum München

Mesenchymal TNFR2 promotes the development of polyarthritis and comorbid heart valve stenosis.

JCI insight 3:98864 (2018)
Publishers Version DOI PMC
Free by publisher
Open Access Green as soon as Postprint is submitted to ZB.
Mesenchymal TNF signaling is etiopathogenic for inflammatory diseases such as rheumatoid arthritis and spondyloarthritis (SpA). The role of Tnfr1 in arthritis has been documented; however, Tnfr2 functions are unknown. Here, we investigate the mesenchymal-specific role of Tnfr2 in the Tnf(1ARE) mouse model of SpA in arthritis and heart valve stenosis comorbidity by cell-specific, Col6a1-cre-driven gene targeting. We find that TNF/Tnfr2 signaling in resident synovial fibroblasts (SFs) and valvular interstitial cells (VICs) is detrimental for both pathologies, pointing to common cellular mechanisms. In contrast, systemic Tnfr2 provides protective signaling, since its complete deletion leads to severe deterioration of both pathologies. SFs and VICs lacking Tnfr2 fail to acquire pathogenic activated phenotypes and display increased expression of antiinflammatory cytokines associated with decreased Akt signaling. Comparative RNA sequencing experiments showed that the majority of the deregulated pathways in Tnf(1ARE) mesenchymal-origin SFs and VICs, including proliferation, inflammation, migration, and disease-specific genes, are regulated by Tnfr2; thus, in its absence, they are maintained in a quiescent nonpathogenic state. Our data indicate a pleiotropy of Tnfr2 functions, with mesenchymal Tnfr2 driving cell activation and arthritis/valve stenosis pathogenesis only in the presence of systemic Tnfr2, whereas nonmesenchymal Tnfr2 overcomes this function, providing protective signals and, thus, containing both pathologies.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Keywords Arthritis ; Autoimmunity; Tumor-necrosis-factor; Experimental Autoimmune Encephalomyelitis; Valvular Interstitial-cells; Rheumatoid-arthritis; Receptor 2; Cardiovascular Comorbidity; Pathogenic Principle; Synovial Fibroblast; Factor-alpha; In-vitro
Reviewing status